RxDoctor Payments Data

Philip Kantoff

Medical Oncology · New York, NYNPI 1235107871

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $17,898 of the $17,898 with a category attached, or 100.0%. Merck accounts for 90.7% of it on its own, with 1 other manufacturer making up the rest.

$17,898in general payments, 2019–2025

Across 24 payments — averaging $745.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$16K
  • F. Hoffmann-la Roche AG$2K
$625,000in research payments, 2019–2025

Across 5 payments — averaging $125,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Scientific Affairs, LLC$625K

What the payments were for

  • Consulting fees$17,898100%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck22$16,233
F. Hoffmann-la Roche AG2$1,665

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,898 in reported general payments places this provider in the 65th percentile of 498 medical oncology providers in New York.

See all medical oncology providers in New York →

Other medical oncology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →